Healthcare · Industry
Drug Manufacturers - Specialty & Generic - List & Prices (103 stocks)
All 103 Drug Manufacturers - Specialty & Generic stocks listed, ranked by market capitalization — 3 page(s), 50 per page.
What Are the Leading Drug Manufacturers - Specialty & Generic Stocks?
Prices: Sep 4, 2026 closeThere are 103 publicly traded Drug Manufacturers - Specialty & Generic stocks. The largest by market capitalization are TAK, TEVA, HLN, ZTS, UTHR, VTRS, NBIX, ELAN, RDY, ALKS.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | TAK | $18.45 | $58.92B | 3.34% | |
| Teva Pharmaceutical Industries Limited | TEVA | $36.36 | $42.37B | 60.6 | — |
| Haleon plc | HLN | $9.60 | $42.22B | 20.0 | 2.06% |
| Zoetis Inc. | ZTS | $75.81 | $31.33B | 12.4 | 2.78% |
| United Therapeutics Corporation | UTHR | $487.61 | $20.91B | 17.6 | — |
| Viatris Inc. | VTRS | $16.88 | $19.39B | 2.84% | |
| Neurocrine Biosciences, Inc. | NBIX | $155.64 | $15.82B | 22.8 | — |
| Elanco Animal Health Incorporated | ELAN | $24.50 | $12.24B | — | |
| Dr. Reddy's Laboratories Limited | RDY | $11.97 | $9.97B | 28.5 | 0.69% |
| Alkermes plc | ALKS | $46.10 | $7.73B | 124.6 | — |
| Apotex Health Corp. | APTX.TO | CA$33.63 | CA$7.68B | 0.18% | |
| Lantheus Holdings, Inc. | LNTH | $100.97 | $6.59B | 24.2 | — |
| Hims & Hers Health, Inc. | HIMS | $27.71 | $6.47B | — | |
| Liquidia Corporation | LQDA | $68.66 | $6.15B | 49.0 | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | $77.91 | $6.08B | 81.2 | — |
| Amneal Pharmaceuticals, Inc. | AMRX | $17.44 | $6.07B | 37.1 | — |
| Indivior Pharmaceuticals, Inc. | INDV | $34.94 | $4.12B | 12.5 | — |
| Amylyx Pharmaceuticals, Inc. | AMLX | $34.10 | $3.80B | — | |
| Curaleaf Holdings, Inc. | CURA.TO | CA$13.72 | CA$3.63B | — | |
| BioCryst Pharmaceuticals, Inc. | BCRX | $9.96 | $2.55B | — | |
| Supernus Pharmaceuticals, Inc. | SUPN | $43.53 | $2.53B | — | |
| Prestige Consumer Healthcare Inc. | PBH | $52.26 | $2.48B | 14.7 | — |
| Bausch Health Companies Inc. | BHC | $6.56 | $2.45B | — | |
| HUTCHMED (China) Limited | HCM | $14.09 | $2.45B | 140.9 | — |
| Trulieve Cannabis Corp. | TRLV | $12.11 | $2.33B | — | |
| Avadel Pharmaceuticals plc | AVDL | $21.64 Feb 13, 2026 | $2.13B | — | — |
| Perrigo Company plc | PRGO | $14.92 | $2.06B | 7.77% | |
| Alvotech | ALVO | $5.32 | $1.90B | — | |
| Dynavax Technologies Corporation | DVAX | $15.50 Feb 10, 2026 | $1.82B | — | |
| Eton Pharmaceuticals, Inc. | ETON | $58.45 | $1.67B | 149.9 | — |
| ANI Pharmaceuticals, Inc. | ANIP | $71.23 | $1.64B | 15.7 | — |
| Xeris Biopharma Holdings, Inc. | XERS | $8.53 | $1.56B | — | |
| Phibro Animal Health Corporation | PAHC | $38.25 | $1.55B | 15.9 | 1.24% |
| Harrow, Inc. | HROW | $38.54 | $1.44B | — | |
| Cronos Group Inc. | CRON | $3.26 | $1.20B | 17.2 | — |
| Pacira BioSciences, Inc. | PCRX | $26.35 | $1.05B | 75.3 | — |
| Amphastar Pharmaceuticals, Inc. | AMPH | $23.18 | $986.03M | 13.7 | — |
| Knight Therapeutics Inc. | GUD.TO | CA$10.01 | CA$983.30M | 66.7 | — |
| Glass House Brands Inc. | GLAS | $8.88 | $836.87M | — | |
| Esperion Therapeutics, Inc. | ESPR | $3.18 Jul 13, 2026 | $803.19M | — | — |
| Collegium Pharmaceutical, Inc. | COLL | $23.53 | $729.41M | 18.5 | — |
| Ironwood Pharmaceuticals, Inc. | IRWD | $4.26 | $703.92M | 5.4 | — |
| Aquestive Therapeutics, Inc. | AQST | $5.34 | $670.23M | — | |
| Evotec SE | EVO | $1.86 | $661.02M | — | |
| Canopy Growth Corporation | WEED.TO | CA$1.35 | CA$642.01M | — | |
| Tilray Brands, Inc. | TLRY | $4.50 | $619.11M | — | |
| Evolus, Inc. | EOLS | $9.30 | $614.27M | — | |
| Kamada Ltd. | KMDA | $8.54 | $492.71M | 21.9 | 2.05% |
| BioAge Labs, Inc. | BIOA | $9.59 | $440.15M | — | |
| Alpha Teknova, Inc. | TKNO | $6.92 | $371.52M | — |
Takeda Pharmaceutical Company Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $58.92B
- P/E
- unprofitable
- Dividend Yield
- 3.34%
Teva Pharmaceutical Industries Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $42.37B
- P/E
- 60.6
Haleon plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $42.22B
- P/E
- 20.0
- Dividend Yield
- 2.06%
Zoetis Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $31.33B
- P/E
- 12.4
- Dividend Yield
- 2.78%
United Therapeutics Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $20.91B
- P/E
- 17.6
Viatris Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $19.39B
- P/E
- unprofitable
- Dividend Yield
- 2.84%
Neurocrine Biosciences, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $15.82B
- P/E
- 22.8
Elanco Animal Health Incorporated
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $12.24B
- P/E
- unprofitable
Dr. Reddy's Laboratories Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $9.97B
- P/E
- 28.5
- Dividend Yield
- 0.69%
Alkermes plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $7.73B
- P/E
- 124.6
Apotex Health Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$7.68B
- P/E
- unprofitable
- Dividend Yield
- 0.18%
Lantheus Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.59B
- P/E
- 24.2
Hims & Hers Health, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.47B
- P/E
- unprofitable
Liquidia Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.15B
- P/E
- 49.0
Kiniksa Pharmaceuticals International, plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.08B
- P/E
- 81.2
Amneal Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.07B
- P/E
- 37.1
Indivior Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $4.12B
- P/E
- 12.5
Amylyx Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $3.80B
- P/E
- unprofitable
Curaleaf Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$3.63B
- P/E
- unprofitable
BioCryst Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.55B
- P/E
- unprofitable
Supernus Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.53B
- P/E
- unprofitable
Prestige Consumer Healthcare Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.48B
- P/E
- 14.7
Bausch Health Companies Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.45B
- P/E
- unprofitable
HUTCHMED (China) Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.45B
- P/E
- 140.9
Trulieve Cannabis Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.33B
- P/E
- unprofitable
Avadel Pharmaceuticals plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.13B
Perrigo Company plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.06B
- P/E
- unprofitable
- Dividend Yield
- 7.77%
Alvotech
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.90B
- P/E
- unprofitable
Dynavax Technologies Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.82B
- P/E
- unprofitable
Eton Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.67B
- P/E
- 149.9
ANI Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.64B
- P/E
- 15.7
Xeris Biopharma Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.56B
- P/E
- unprofitable
Phibro Animal Health Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.55B
- P/E
- 15.9
- Dividend Yield
- 1.24%
Harrow, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.44B
- P/E
- unprofitable
Cronos Group Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.20B
- P/E
- 17.2
Pacira BioSciences, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.05B
- P/E
- 75.3
Amphastar Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $986.03M
- P/E
- 13.7
Knight Therapeutics Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$983.30M
- P/E
- 66.7
Glass House Brands Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $836.87M
- P/E
- unprofitable
Esperion Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $803.19M
Collegium Pharmaceutical, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $729.41M
- P/E
- 18.5
Ironwood Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $703.92M
- P/E
- 5.4
Aquestive Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $670.23M
- P/E
- unprofitable
Evotec SE
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $661.02M
- P/E
- unprofitable
Canopy Growth Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$642.01M
- P/E
- unprofitable
Tilray Brands, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $619.11M
- P/E
- unprofitable
Evolus, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $614.27M
- P/E
- unprofitable
Kamada Ltd.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $492.71M
- P/E
- 21.9
- Dividend Yield
- 2.05%
BioAge Labs, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $440.15M
- P/E
- unprofitable
Alpha Teknova, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $371.52M
- P/E
- unprofitable
Showing 1–50 of 103 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data. Ranked by market capitalization. Prices are the most recent daily close.
Which Drug Manufacturers - Specialty & Generic Stocks Are Reasonably Valued?
Prices: Sep 4, 2026 closeAmong the 50 largest Drug Manufacturers - Specialty & Generic companies, Ironwood Pharmaceuticals, Inc. (IRWD) trades at the lowest trailing P/E ratio, 5.4. The industry average is 37.5.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. | IRWD | $4.26 | $703.92M | 5.4 | — |
| Zoetis Inc. | ZTS | $75.81 | $31.33B | 12.4 | 2.78% |
| Indivior Pharmaceuticals, Inc. | INDV | $34.94 | $4.12B | 12.5 | — |
| Amphastar Pharmaceuticals, Inc. | AMPH | $23.18 | $986.03M | 13.7 | — |
| Prestige Consumer Healthcare Inc. | PBH | $52.26 | $2.48B | 14.7 | — |
Ranked by trailing twelve-month P/E, lowest first. Companies that report no P/E are not listed. Rankings cover the 50 largest Drug Manufacturers - Specialty & Generic companies by market capitalization.
Which Drug Manufacturers - Specialty & Generic Stocks Pay the Highest Dividends?
Prices: Sep 4, 2026 close9 of the 50 largest Drug Manufacturers - Specialty & Generic companies pay a dividend. Perrigo Company plc (PRGO) has the highest yield at 7.77%.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Perrigo Company plc | PRGO | $14.92 | $2.06B | 7.77% | |
| Takeda Pharmaceutical Company Limited | TAK | $18.45 | $58.92B | 3.34% | |
| Viatris Inc. | VTRS | $16.88 | $19.39B | 2.84% | |
| Zoetis Inc. | ZTS | $75.81 | $31.33B | 12.4 | 2.78% |
| Haleon plc | HLN | $9.60 | $42.22B | 20.0 | 2.06% |
Ranked by trailing dividend yield, highest first. Companies that pay no dividend are not listed. Rankings cover the 50 largest Drug Manufacturers - Specialty & Generic companies by market capitalization.
Key facts
As of September 4, 2026, 103 Drug Manufacturers - Specialty & Generic stocks are listed on NYSE/NASDAQ and TSX.
The largest by market capitalization is Takeda Pharmaceutical Company Limited (TAK) at $58.92B.
The median P/E across the Drug Manufacturers - Specialty & Generic industry is 19.3.
Drug Manufacturers - Specialty & Generic Industry Overview
From the data · Sep 4, 2026The Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, includes 103 publicly traded companies with a combined market capitalization of $359.13B. The industry is led by Takeda Pharmaceutical Company Limited (TAK), Teva Pharmaceutical Industries Limited (TEVA), Haleon plc (HLN).
Among the 103 listed Drug Manufacturers - Specialty & Generic companies, market capitalizations range from $58.92B (Takeda Pharmaceutical Company Limited) down to $20.91B (United Therapeutics Corporation), highlighting the wide size disparity across the industry. The average market cap across the industry is $3.49B, reflecting a mix of established large-cap players and smaller growth-oriented companies.
Drug Manufacturers - Specialty & Generic Industry Valuation
The Drug Manufacturers - Specialty & Generic industry currently trades at an average price-to-earnings (P/E) ratio of 37.5. This elevated multiple indicates that investors are pricing in strong future earnings growth across Drug Manufacturers - Specialty & Generic companies. Note that some companies in the industry report no P/E ratio, typically because they are currently unprofitable or in early growth stages.
Drug Manufacturers - Specialty & Generic Dividend Profile
9 out of 103 Drug Manufacturers - Specialty & Generic companies (9%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Drug Manufacturers - Specialty & Generic stocks is 2.55%. Most Drug Manufacturers - Specialty & Generic companies reinvest earnings into growth rather than paying dividends, which is typical for earlier-stage or high-growth industries.
Frequently Asked Questions
What are the leading Drug Manufacturers - Specialty & Generic stocks?
The largest Drug Manufacturers - Specialty & Generic stocks by market capitalization are Takeda Pharmaceutical Company Limited (TAK), Teva Pharmaceutical Industries Limited (TEVA), Haleon plc (HLN), Zoetis Inc. (ZTS), United Therapeutics Corporation (UTHR). All 103 companies are ranked by market cap on this page.
Where can I find a complete list of Drug Manufacturers - Specialty & Generic stocks?
This page is the complete list: 103 Drug Manufacturers - Specialty & Generic companies across 3 page(s), 50 per page, ranked by market capitalization — including TAK, TEVA, HLN, ZTS, UTHR.
How many Drug Manufacturers - Specialty & Generic stocks are there?
There are 103 publicly traded Drug Manufacturers - Specialty & Generic companies listed on major US exchanges, ranging from Takeda Pharmaceutical Company Limited (TAK) to United Therapeutics Corporation (UTHR) by market capitalization. This directory spans 3 pages, with all companies sorted by market cap for easy comparison.
Which Drug Manufacturers - Specialty & Generic stocks are reasonably valued?
Among the 50 largest Drug Manufacturers - Specialty & Generic companies, Ironwood Pharmaceuticals, Inc. (IRWD) carries the lowest trailing P/E at 5.4, against an industry average of 37.5.
Which Drug Manufacturers - Specialty & Generic stocks have the highest dividend yield?
9 of the 103 Drug Manufacturers - Specialty & Generic companies (9%) pay a dividend, with an average yield of 2.55% among payers. The highest yield among the 50 largest is Perrigo Company plc (PRGO) at 7.77%.
Explore Drug Manufacturers - Specialty & Generic Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 103 Drug Manufacturers - Specialty & Generic companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Drug Manufacturers - Specialty & Generic stocks head to head. All data is updated regularly to reflect the latest available financials.